Nano-cap biotech Sensei surges on $200M private placement, acquisition
Source: SeekingAlpha
2026-02-18 11:47:16 ET
More on Sensei Biotherapeutics
- Seeking Alpha’s Quant Rating on Sensei Biotherapeutics
- Historical earnings data for Sensei Biotherapeutics
- Financial information for Sensei Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
Nano-cap biotech Sensei surges on $200M private placement, acquisition
Sensei Biotherapeutics Inc.
NASDAQ: SNSE
SNSE Trading
-5.35% G/L:
$29.04 Last:
49,702 Volume:
$28.86 Open:
SNSE Latest News
February 25, 2026 06:00:00 am
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2026 09:23:39 am
Execution Day: Transgenic Manufacturing, Enterprise AI Deployment, and Strategic M&A Drive Early Momentum
February 18, 2026 08:00:00 am
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
SNSE Stock Data
$11,124,578
968,671
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville
